Further studies showed that the protective role of microglial Rack1 deficiency in AD was mediated by IGF1‐IGF1R signaling between microglia and astrocytes, highlighting an important regulatory pathway in glial activation within AD pathology. Here, IGF1 is linked to Alzheimer disease.